These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6985960

  • 41. Adenosine analogues as inhibitors of P2Y12 receptor mediated platelet aggregation.
    Douglass JG, deCamp JB, Fulcher EH, Jones W, Mahanty S, Morgan A, Smirnov D, Boyer JL, Watson PS.
    Bioorg Med Chem Lett; 2008 Mar 15; 18(6):2167-71. PubMed ID: 18276138
    [Abstract] [Full Text] [Related]

  • 42. Effect of sulphated polysaccharides on prostacyclin (prostaglandin I2)-induced inhibition of platelet aggregation [proceedings].
    Kindness G, Williamson FB, Long WF.
    Biochem Soc Trans; 1980 Jun 15; 8(3):377-9. PubMed ID: 6995209
    [No Abstract] [Full Text] [Related]

  • 43. Stimulation of coronary vascular prostacyclin and inhibition of human platelet thromboxane A2 after low-dose nitroglycerin.
    Schrör K, Grodzinska L, Darius H.
    Thromb Res; 1980 Jun 15; 23(1-2):59-67. PubMed ID: 6795756
    [No Abstract] [Full Text] [Related]

  • 44. Prostacyclin release induced by bradykinin may contribute to the antihypertensive action of angiotensin-converting enzyme inhibitors.
    Mullane KM, Moncada S, Vane JR.
    Adv Prostaglandin Thromboxane Res; 1980 Jun 15; 7():1159-61. PubMed ID: 6245567
    [No Abstract] [Full Text] [Related]

  • 45. Role of the eosinophil in the allergic reactions. II. Release of prostaglandins from human eosinophilic leukocytes.
    Hubscher T.
    J Immunol; 1975 Apr 15; 114(4):1389-93. PubMed ID: 46901
    [Abstract] [Full Text] [Related]

  • 46. Loss of anti-aggregatory effects of aortic valve tissue in patients with aortic stenosis.
    Chirkov YY, Mishra K, Chandy S, Holmes AS, Kanna R, Horowitz JD.
    J Heart Valve Dis; 2006 Jan 15; 15(1):28-33. PubMed ID: 16480009
    [Abstract] [Full Text] [Related]

  • 47. Adenine nucleotides as tools in platelet studies.
    Maguire MH.
    Proc West Pharmacol Soc; 1981 Jan 15; 24():381-4. PubMed ID: 7255483
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Renal biosynthesis of prostacyclin and thromboxane: relationship between renal release of prostacyclin and thromboxane and tissue pressure.
    Okahara T, Fukui K, Tamaki T, Fujioka S, Abe Y.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Jan 15; 15():419-22. PubMed ID: 2936134
    [No Abstract] [Full Text] [Related]

  • 50. A prospective method for thrombotic diseases using prostaglandin I2.
    Isobe J, Mizuno A.
    Tokushima J Exp Med; 1982 Jun 15; 29(1-2):95-101. PubMed ID: 6755803
    [No Abstract] [Full Text] [Related]

  • 51. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB, Araki H, Lefer AM.
    Circulation; 1980 Dec 15; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [Abstract] [Full Text] [Related]

  • 52. Release of adenosine and prostacyclin from ischemic human hearts.
    Edlund A, Berglund B, Kaijser L, Patrono C, Sollevi A, van Dorne D, Wennmalm A.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Dec 15; 11():365-70. PubMed ID: 6221547
    [No Abstract] [Full Text] [Related]

  • 53. Is the platelet defect in Bartter's syndrome associated with a plasma prostaglandin?
    MacIntyre DE, Smith M, Levine L, Stoff JS, Stemerman M, Steer ML, Salzman EW, Brown RS.
    Adv Prostaglandin Thromboxane Res; 1980 Dec 15; 7():1199-202. PubMed ID: 7369031
    [No Abstract] [Full Text] [Related]

  • 54. Synthesis of ciloprost (ZK 36 374): a chemically stable and biologically potent prostacyclin analog.
    Skuballa W, Vorbrüggen H.
    Adv Prostaglandin Thromboxane Leukot Res; 1983 Dec 15; 11():299-305. PubMed ID: 6189381
    [No Abstract] [Full Text] [Related]

  • 55. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation.
    Gryglewski RJ, Korbut R, Ocetkiewicz A.
    Nature; 1978 Jun 29; 273(5665):765-7. PubMed ID: 351417
    [No Abstract] [Full Text] [Related]

  • 56. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ, Sitko GR, Holahan MA, Stranieri MT, Glass JD, Askew BC, McIntyre CJ, Claremon DA, Baldwin JJ, Hartman GD, Gould RJ, Lynch JJ.
    J Pharmacol Exp Ther; 1997 May 29; 281(2):677-89. PubMed ID: 9152373
    [Abstract] [Full Text] [Related]

  • 57. Cardiovascular and antithrombotic effects of ZK 96 480, a novel metabolically stable carbacyclin derivative with oral activity.
    Stürzebecher CS, Loge O, Schröder G, Müller B, Witt W.
    Prog Clin Biol Res; 1987 May 29; 242():425-31. PubMed ID: 3313417
    [No Abstract] [Full Text] [Related]

  • 58. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
    Salvemini D, Currie MG, Mollace V.
    J Clin Invest; 1996 Jun 01; 97(11):2562-8. PubMed ID: 8647949
    [Abstract] [Full Text] [Related]

  • 59. Effects of prostacyclin analogues on platelet aggregation and blood pressure of anaesthetized beagle dogs.
    Hermán F, Hadházy P, Magyar K, Kovács G.
    Prog Clin Biol Res; 1987 Jun 01; 242():101-6. PubMed ID: 3313407
    [No Abstract] [Full Text] [Related]

  • 60. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
    Cook NS, Bruttger O, Pally C, Hagenbach A.
    Thromb Haemost; 1993 Nov 15; 70(5):838-47. PubMed ID: 8128443
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.